Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-008898
Filing Date
2023-08-15
Accepted
2023-08-15 16:30:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27673
2 filename2.txt TEXT-EXTRACT 1518
  Complete submission text file 0000000000-23-008898.txt   40390
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filed for) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations